Innovation Pharmaceuticals Inc (IPIX)

[CallMeCrazy]

This caught my eye in today's PR:

commented Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Innovation Pharmaceuticals. “Only a handful of patient follow-up visits remain to be completed..."

I interpret "handful" to be 4-5 patients and since there were 199 enrolled patients, this suggests 194-5 patients have completed the P2B oral prurisol trial. If this is true then it seems that, although the last patient follow-up visit will not occur until Dec. 28, IPIX and prurisol's BP/CDA holders have enough data (from the 194-5 patients) to begin 'hammering' out an agreement.

I think an agreement/partnership is POSSIBLE by the first of the year; PROBABLE in the first quarter of the year.

http://mailchi.mp/ipharminc/final-patient-completes-treatment-in-innovation-pharmaceuticals-phase-2b-study-of-oral-prurisol-for-psoriasis?e=d6a81bdb11